Media Centre

Featured Media Release

08 Jan 2015 - ADELAIDE HILLS BUSHFIRES: Donation of asthma medication

GSK has responded to the South Australian bushfire emergency by providing eight pharmacies in the Adelaide Hills fire affected areas with a donation of asthma rescue medicine.


Media Releases

Australians seek greater clarity on payments to doctors

The majority of Australians approve of pharmaceutical company financial support for doctors and the healthcare system in general, as long as the arrangement is declared openly, according to the results of an online survey conducted this month by...



New PBS listing of REVOLADE® (eltrombopag olamine) tablets increases access to treatment options for Australians withchronic ITP

As of 1 November 2011, Australians with the rare blood disorder, chronic immune (idiopathic) thrombocytopenic purpura (ITP), will have increased access to treatment options for chronic ITP with the listing of REVOLADE® (eltrombopag) tablets on the...



Australian Crohn’s sufferers urged to take part in worldwide research into new treatment

Australians suffering from the debilitating bowel condition, Crohn’s disease (CD), are being invited to participate in a worldwide study to assess a potential new treatment which could alleviate symptoms and improve their quality of life.



GSK Patient Support Programs Statement

GSK Australia provides patient support programs as part of a commitment to the quality use of medicines only after they have been prescribed a particular medicine/s.



GSK Awarded Funds to Advance Dermal Treatment with Starpharma’s Dendrimers

GlaxoSmithKline (GSK), and Starpharma (ASX:SPL, OTCQX:SPHRY) today announced that GSK was awarded a grant to advance a dermal treatment based on Starpharma’s dendrimer drug delivery technology.



Worldwide study to help Australians breathe easier needs volunteers

Australian sufferers of chronic obstructive pulmonary disorder (COPD), one of the most important causes of breathlessness and difficulty performing tasks of normal daily life, have the opportunity to participate in a worldwide study, starting this...



PBS listing of new treatment for enlarged prostate

Australian men who suffer from the symptoms of an enlarged prostate – like frequent urination, waking at night to urinate; a sense of incomplete emptying after urination; straining to urinate or a feeling of extreme urgency to urinate1 - now have a...



GSK discloses payments to Australian healthcare professionals

As part of an ongoing commitment to increase transparency, GlaxoSmithKline Australia today disclosed the aggregate amount of fees paid to Australian healthcare professionals and health-related organisations for all sponsorships, grants, speaking...



GSK to disclose payments to healthcare professionals by June 2011

As part of an ongoing commitment to increase transparency, GlaxoSmithKline announced today the intention to publish, by June 2011, the total amount of fees paid to Australian healthcare professionals for speaking and consulting services during 2010.



GSK statement on AvodartTM (dutasteride) for prostate cancer risk reduction

GlaxoSmithKline (GSK) announced today that it will no longer pursue global approval (marketing authorisation) for the use of Avodart® (dutasteride) to reduce the risk of prostate cancer. The Company will withdraw applications from regulatory review...


< 4 5 6 7 8 9 10 11 12 13 14 >